Journal article
Implantable cardioverter–defibrillator therapy in hypertrophic cardiomyopathy: A SIMPLE substudy
Abstract
BACKGROUND: Patients with hypertrophic cardiomyopathy (HCM) are considered to be at high risk for elevated defibrillation thresholds, periprocedural complications, and failed appropriate shocks.
OBJECTIVE: The purpose of this study was to determine the value of defibrillation testing (DT) in HCM patients undergoing implantable cardioverter-defibrillator (ICD) insertion.
Authors
Vamos M; Healey JS; Wang J; Connolly SJ; Mabo P; Van Erven L; Kautzner J; Glikson M; Neuzner J; O'Hara G
Journal
Heart Rhythm, Vol. 15, No. 3, pp. 386–392
Publisher
Elsevier
Publication Date
March 2018
DOI
10.1016/j.hrthm.2017.11.020
ISSN
1547-5271